Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.66
Delayed Data
As of May 18
 +0.04 / +2.47%
Today’s Change
0.98
Today|||52-Week Range
2.65
+38.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization225.0K240.0K268.0K112.0K
 
 
 
 
 
 
Operating ExpensesGross Income-225.0K-240.0K-268.0K-112.0K
 
 
 
 
 
General Expenses18.7M28.2M40.4M34.6M
 
 
 
 
 
Research And Development8.3M15.4M28.4M25.2M
 
 
 
 
 
Total Operating Expenses18.9M28.4M40.7M34.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.9M-28.4M-40.7M-34.7M
 
 
 
 
 
Extraordinary Credit585.0K0.000.000.00
 
 
Extraordinary Charge---9.5M-1.2M0.00
 
 
 
Interest Expense On Debt20.0K20.0K15.0K3.0K
 
 
 
 
 
Other Expenses-48.0K-18.0K-4.0K-33.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.4M-38.0M-41.9M-34.7M
 
 
 
 
 
Income Taxes-12.0K-17.0K-16.0K0.00
 
 
 
 
Net Income-18.4M-38.0M-41.9M-34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.2M26.8M35.2M41.7M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M26.8M35.2M41.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$1.45-$1.19-$0.83
 
 
 
 
 
EPS Diluted-$1.00-$1.45-$1.19-$0.83